Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model

Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and... Objective: Our purpose was to assess the effect of multiple injections of the system of herpes simplex virus thymidine kinase in an adenovirus vector and ganciclovir on survival in a murine model of human epithelial ovarian cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Obstetrics and Gynecology Wolters Kluwer Health

Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model

7 pages

Loading next page...
 
/lp/elsevier/ovarian-cancer-gene-therapy-repeated-treatment-with-thymidine-kinase-NMEyIzox18

References (25)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2000 Mosby, Inc.
ISSN
0002-9378
DOI
10.1067/mob.2000.104837
Publisher site
See Article on Publisher Site

Abstract

Objective: Our purpose was to assess the effect of multiple injections of the system of herpes simplex virus thymidine kinase in an adenovirus vector and ganciclovir on survival in a murine model of human epithelial ovarian cancer.

Journal

American Journal of Obstetrics and GynecologyWolters Kluwer Health

Published: Mar 1, 2000

There are no references for this article.